2021 Volume 56 Issue 4 Pages 331-339
The number of people diagnosed with heart failure (HF) is increasing. Current therapies improve survival for HF with reduced ejection fraction, but a result has been to increase the number of HF patients who progress to advanced disease. Heart transplantation (HTx) offers the best survival for patients with end-stage heart failure. However, with the scarcity of donor organs, the waiting time to transplant continues to lengthen, leading to an increase in the proportion of patients with a left ventricular assist device (LVAD) in Japan. As is widely known, serial assessment of evaluating patients’ candidacy, managing long-term LVAD therapy and intensive perioperative/long-term treatment after HTx are essential to achieve a favorable prognosis. The amount of specialized knowledge and skill required to care for the growing number of patients with HF, including those who require mechanical circulatory supports and/or cardiac transplantation. Accordingly, there is an increasing need for well-trained cardiologists to manage these complex patients.